Skip to main contentSkip to navigation
Sirius Investors

TRSBF Stock: 3SBio Inc. Stock Price, Analysis & Insights

Get live TRSBF stock price $2.20, comprehensive 3SBio Inc. stock analysis, charts, news, and expert forecast. Real-time TRSBF stock data and investment insights.

2.20
10.00%Today
TRSBF3SBio Inc. • Other OTC • Healthcare
Market Cap
5.50B
Volume
1.50K
52W High
4.74
52W Low
2.00

Loading chart data...

3SBio Inc. (TRSBF) Overview

3SBio Inc. (TRSBF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, TRSBF trades at $2.20 with a market capitalization of 5.50B . Over the past 52 weeks, TRSBF has traded between $2.00 and $4.74 , with the current price positioned at approximately 7% of this range . The stock currently trades at a price-to...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 5.50B
  • Current price: $2.20
  • 52-week range: $2.00 - $4.74
  • P/E ratio: 4.31

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

3SBio Inc. is a China-based investment holding company deeply engaged in the biopharmaceutical sector, encompassing the entire value chain from research and development to manufacturing, marketing, and sales of its innovative products. The company's ...

Company Information

CEO
Jing Lou
Sector
Healthcare
Industry
Biotechnology
Employees
5577

Contact Information

Address
No. 3 A1, Road 10
Country
CN

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 4.3)

Lower volatility stock (Beta: 0.47) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for 3SBio Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for 3SBio Inc.
  • Investors should consider how 3SBio Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

5.50B

P/E Ratio (TTM)

4.31

Beta

0.47

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.